ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1836

Suppression Of HDAC5 Expression By Inflammatory Cytokines Is Required To Promote CXCL Chemokine Production In RA FLS

Chiara Angiolilli1, A.M. Grabiec1, P.A. Kabala1, Paul-Peter Tak2, Dominique L. Baeten3 and Kris A. Reedquist4, 1Department of Experimental Immunology, Department of Clinical Immunology and Rheumatology Academic Medical Center, University of Amsterdam, Amsterdam, Netherlands, 2Academic Medical Center / currently also GlaxoSmithKline, Amsterdam, Netherlands, 3Department of Clinical Immunology and Rheumatology Academic Medical Center, University of Amsterdam, Amsterdam, Netherlands, 4Department of Experimental Immunology and Division of Clinical Immunology and Rheumatology, Academic Medical Center, University of Amsterdam, Amsterdam, Netherlands

Meeting: 2013 ACR/ARHP Annual Meeting

Keywords: Histone Modification and epigenetics

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: Biology and Pathology of Bone and Joint (Bone and Arthritis)

Session Type: Abstract Submissions (ACR)

Background/Purpose:

Histone deacetylases (HDACs) are important regulators of gene expression and protein function in the immune system. HDAC inhibitors (HDACi) display anti-inflammatory properties in animal and in vitro models of rheumatoid arthritis (RA), as well as initial safety and efficacy in the treatment of systemic onset juvenile idiopathic arthritis1,2 .However, as most of the currently available HDACi display little selectivity or specificity for class I (HDAC 1-3, 8) and class II (HDAC 4-6, 9, 10) HDACs, the role of specific HDACs in RA is unclear.
We examined the relationship between HDAC expression and inflammation in RA synovial tissue and fibroblast-like synoviocytes (FLS).

Methods:

RNA was isolated from arthroscopic synovial biopsies from 19 RA patients. MMP-1, TNFα, IL-6, and HDAC 1-10 expression was measured by quantitative PCR (qPCR). RA FLS were stimulated with IL-1β, TNFα and LPS and HDAC expression was measured by qPCR. RA FLS were transduced with adenovirus encoding control GFP or GFP-HDAC5, or transfected with control siRNA or siRNA targeting HDAC5. Effects of HDAC5 modulation on RA FLS gene and protein expression were analyzed by custom qPCR array and ELISA, respectively.

Results:

Positive correlations were observed between RA synovial tissue expression of TNFα and HDAC1 (R=0.651, P=0.003) HDAC2 (R=0.523, P=0.022) and HDAC3 (R=0.570, P=0.011) and between MMP-1 and HDAC1 (R=0.501, P=0.029) and HDAC2 (R=0.512, P= 0.025).  A significant negative correlation was observed between synovial tissue expression HDAC5 and IL-6 (R=-0.477, P= 0.039), as well as HDAC5 and clinical parameters of disease activity (CRP: R=-0.664, P= 0.007; ESR: R=-0.556, P=0.013: DAS28: R=-0.567, P=0.011). HDAC5 mRNA expression was significantly and selectively reduced after RA FLS stimulation with TNFα and IL-1β, but not LPS. Of 84 genes regulated in RA FLS by IL-1β or TNFα, mRNA expression of CXCL9, CXCL10, and CXCL11, as well as CXCL10 protein, were selectively upregulated following silencing of HDAC5 expression. Conversely, mRNA expression of these chemokines was suppressed by overexpression of HDAC5 in RA FLS.

Conclusion:

RA synovial expression of HDAC 1 and 2, but not class II HDACs, positively correlates with local inflammatory mediators, while HDAC5 expression negatively correlates with IL-6 mRNA expression and with disease activity parameters. HDAC5 mRNA is decreased after inflammatory stimulation, and silencing of HDAC5 leads to an increase of CXCL chemokine expression in RA FLS, an effect reversed by HDAC5 overexpression. Our results suggest an involvement of HDAC5 in the regulation of a specific subset of IL-1β induced CXCL chemokines RA FLS.


Disclosure:

C. Angiolilli,
None;

A. M. Grabiec,
None;

P. A. Kabala,
None;

P. P. Tak,
None;

D. L. Baeten,
None;

K. A. Reedquist,
None.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2013 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/suppression-of-hdac5-expression-by-inflammatory-cytokines-is-required-to-promote-cxcl-chemokine-production-in-ra-fls/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology